论文部分内容阅读
英国政府、工业界和科技界正集中力量,以便在全球日新月异的基因研究和开发的竞争中占据领先地位。这场竞争威胁着英国制药工业—英国唯一的、至今在制造业中仍无可争辩地位居世界之首的行业。英国的制药业始终以传统的化学工业为基础。近20年,一个建立在基因工程之上的、以致病的最终原因—对每一生命过程发出指令的基因为目标的新型工业即将出现,使英国制药工业的基础受到了严峻的挑战。英国的一些有识之士认为:英国以化工为驱动力的制药工业的成功历史,并不意味着英国在未来的、以微生物学为基础的新型工业中
The British government, industry and technology are focusing their efforts to take the lead in the ever-changing competition for genetic research and development in the world. The competition threatens the British pharmaceutical industry, the only one in the UK that has so far been the undisputed leader in manufacturing. The pharmaceutical industry in the United Kingdom has always been based on the traditional chemical industry. In the last 20 years, a new industry based on genetic engineering that targets the ultimate cause of illness - aiming for instructions for every life process - is on the horizon, posing a serious challenge to the foundations of the British pharmaceutical industry. Some people in the United Kingdom believe that the successful history of the chemical-driven pharmaceutical industry in the United Kingdom does not mean that the United Kingdom has a long history in the future of new microbiology-based industries